Morningstar Investment Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.76M Hold
73,982
0.23% 106
2026
Q1
$3.76M Buy
73,982
+3,127
+4% +$146K 0.23% 106
2025
Q4
$2.09M Hold
70,855
0.12% 159
2025
Q3
$1.83M Buy
+70,855
New +$1.98M 0.07% 263

Other funds holding MRNA

Morningstar Investment Management's MRNA Position: Q2 2026 in Review

Morningstar Investment Management held its Moderna (MRNA) position steady in Q2 2026 at 73,982 shares worth $3.76M. The position accounts for 0.23% of the portfolio, ranked #106.

Morningstar Investment Management first reported a position in MRNA in Q3 2025 and has held it in 4 quarters since. 302 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Morningstar Investment Management held 73,982 shares of Moderna worth $3.76M as of Q2 2026.
  • Morningstar Investment Management left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 0.23% of Morningstar Investment Management's portfolio in Q2 2026, its #106 holding.
  • Morningstar Investment Management first reported a position in Moderna in Q3 2025 and has held it in 4 quarters since.
  • 302 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Morningstar Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.